Scaffold modified Vemurafenib analogues as highly selective mitogen activated protein kinase kinase 4 (MKK4) inhibitors

Authors
Publication date
1 January 2022
Publisher
Elsevier France - Editions Scientifiques Medicales Elsevier
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Publikationsserver der Universität Tübingen

      redirect
      oaioai:publikationen.uni-tuebinge...
      Last time updated on 23/11/2023